SG11201503281QA - Use of pidotimod to treat atopic dermatitis - Google Patents

Use of pidotimod to treat atopic dermatitis

Info

Publication number
SG11201503281QA
SG11201503281QA SG11201503281QA SG11201503281QA SG11201503281QA SG 11201503281Q A SG11201503281Q A SG 11201503281QA SG 11201503281Q A SG11201503281Q A SG 11201503281QA SG 11201503281Q A SG11201503281Q A SG 11201503281QA SG 11201503281Q A SG11201503281Q A SG 11201503281QA
Authority
SG
Singapore
Prior art keywords
pidotimod
atopic dermatitis
treat atopic
treat
dermatitis
Prior art date
Application number
SG11201503281QA
Other languages
English (en)
Inventor
Federico Mailland
Maurizio Caserini
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of SG11201503281QA publication Critical patent/SG11201503281QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201503281QA 2012-12-19 2012-12-19 Use of pidotimod to treat atopic dermatitis SG11201503281QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/076086 WO2014094839A1 (en) 2012-12-19 2012-12-19 Use of pidotimod to treat atopic dermatitis

Publications (1)

Publication Number Publication Date
SG11201503281QA true SG11201503281QA (en) 2015-07-30

Family

ID=47520053

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201503281QA SG11201503281QA (en) 2012-12-19 2012-12-19 Use of pidotimod to treat atopic dermatitis

Country Status (32)

Country Link
US (1) US20150352081A1 (es)
EP (1) EP2934520B1 (es)
JP (1) JP6058156B2 (es)
KR (1) KR20150095772A (es)
CN (1) CN104797254B (es)
AU (1) AU2012396941A1 (es)
BR (1) BR112015011394A2 (es)
CA (1) CA2889388A1 (es)
CY (1) CY1118633T1 (es)
DK (1) DK2934520T3 (es)
EA (1) EA201591184A1 (es)
EC (1) ECSP15025570A (es)
ES (1) ES2615748T3 (es)
HK (1) HK1210938A1 (es)
HR (1) HRP20161667T1 (es)
HU (1) HUE030408T2 (es)
IL (1) IL239292A0 (es)
LT (1) LT2934520T (es)
MA (1) MA38156B1 (es)
ME (1) ME02559B (es)
MX (1) MX2015008129A (es)
PH (1) PH12015501211A1 (es)
PL (1) PL2934520T3 (es)
PT (1) PT2934520T (es)
RS (1) RS55424B1 (es)
SG (1) SG11201503281QA (es)
SI (1) SI2934520T1 (es)
SM (1) SMT201700071B (es)
TN (1) TN2015000159A1 (es)
UY (1) UY35197A (es)
WO (1) WO2014094839A1 (es)
ZA (1) ZA201502983B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015036009A1 (en) * 2013-09-10 2015-03-19 Polichem S.A. Pidotimod for use in the treatment of inflammation-associated diseases
EP3754806A1 (en) 2019-06-19 2020-12-23 UTC Fire & Security EMEA BVBA Power supply device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231723B (it) * 1989-08-11 1991-12-21 Poli Ind Chimica Spa Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmaceutiche che li contengono
EP1482972A4 (en) * 2001-11-20 2005-11-23 Seattle Genetics Inc TREATMENT OF IMMUNOLOGICAL DISORDERS USING ANTI-CD30 ANTIBODIES
EP1688161A1 (en) * 2004-11-02 2006-08-09 Switch Biotech Aktiengesellschaft Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
TW200711649A (en) * 2005-06-17 2007-04-01 Combinatorx Inc Combination therapy for the treatment of immunoinflammatory disorders

Also Published As

Publication number Publication date
AU2012396941A2 (en) 2015-06-18
MX2015008129A (es) 2015-09-23
DK2934520T3 (en) 2017-01-23
MA38156A1 (fr) 2016-08-31
EA201591184A1 (ru) 2015-10-30
ME02559B (me) 2017-02-20
JP2016503042A (ja) 2016-02-01
KR20150095772A (ko) 2015-08-21
RS55424B1 (sr) 2017-04-28
CN104797254A (zh) 2015-07-22
BR112015011394A2 (pt) 2017-07-11
ECSP15025570A (es) 2016-01-29
ES2615748T3 (es) 2017-06-08
IL239292A0 (en) 2015-07-30
CY1118633T1 (el) 2017-07-12
LT2934520T (lt) 2017-01-10
AU2012396941A1 (en) 2015-05-28
PT2934520T (pt) 2017-02-16
CN104797254B (zh) 2017-06-06
JP6058156B2 (ja) 2017-01-11
MA38156B1 (fr) 2017-03-31
EP2934520B1 (en) 2016-11-16
US20150352081A1 (en) 2015-12-10
SMT201700071B (it) 2017-03-08
WO2014094839A1 (en) 2014-06-26
HUE030408T2 (en) 2017-05-29
PH12015501211A1 (en) 2015-08-17
CA2889388A1 (en) 2014-06-26
PL2934520T3 (pl) 2017-08-31
UY35197A (es) 2014-06-30
TN2015000159A1 (en) 2016-10-03
EP2934520A1 (en) 2015-10-28
HK1210938A1 (en) 2016-05-13
ZA201502983B (en) 2016-11-30
HRP20161667T1 (hr) 2017-01-27
SI2934520T1 (sl) 2017-03-31

Similar Documents

Publication Publication Date Title
HK1219414A1 (zh) 治療關節炎的方法
HK1205759A1 (en) Treatment of biomass
HRP20181000T1 (hr) Postupci liječenja stanja povezanih s kosom
IL237862A0 (en) Methods to reduce the formation of scale
GB201309274D0 (en) Treatment Of Fuel
HK1210937A1 (en) Use of pidotimod to treat psoriasis
HK1210938A1 (en) Use of pidotimod to treat atopic dermatitis
GB201221118D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201206325D0 (en) Methods of treatment
GB201206324D0 (en) Methods of treatment
GB201206326D0 (en) Methods of treatment
GB201206330D0 (en) Methods of treatment
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment
GB201212717D0 (en) Treatment of musculoskeletal conditions